Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) released its quarterly earnings results on Thursday. Cullinan Therapeutics Stock PerformanceShares of NASDAQ:CGEM traded down $0.22 during trading on Friday, reaching $17.73. Cullinan Therapeutics has a 52 week low of $5.68 and a 52 week high of $19.43. Insider Buying and Selling at Cullinan TherapeuticsIn related news, insider Jennifer Michaelson sold 8,000 shares of Cullinan Therapeutics stock in a transaction on Monday, July 6th. See AlsoReceive News & Ratings for Cullinan Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullinan Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.